Oliver Bisazza

Chief Executive Officer, MedTech Europe

Oliver joined MedTech Europe in 2017, originally heading the department which supports members in implementing new and changing EU regulatory requirements affecting the medical technology industry.

In January 2023, Oliver assumed the role of Chief Executive Officer, responsible for the association’s overall management and strategy and reporting to the Board of Directors.

Oliver’s passion is to see the value of medical technology innovation fully recognised as a source of solutions to the many challenges facing healthcare systems, economies and societies, both in Europe and around the world.

Prior to joining MedTech Europe, he worked at Medtronic as Director of Regulatory Policy for EMEA.

In addition to this company experience, Oliver had various trade association roles in Brussels, at COCIR (the European association for the radiological, electromedical and healthcare IT industries) and at EDANA (the industry association for the nonwovens and related industries).

Oliver is a native speaker of English, and a dual national of Australia and Malta.

5 blogs from the author


Posted on 14.03.2024

Building resilient healthcare systems in Europe

MedTech Europe Manifesto: The EU has a key role in preparing for future challenges, from AMR and climate to global trade distortions and supply chain disruption  European health systems have faced severe stress tests in recent years, revealing some of the strengths and weaknesses of our services and institutions. Learning from this experience will be […]

By Oliver Bisazza Chief Executive Officer, MedTech Europe

Posted on 07.02.2024

Empowering patients will boost the quality of healthcare

The MedTech Europe Manifesto: A four-point plan for how the EU can do more for our wellbeing ‒ patients must be centre to building a healthy future Across Europe, campaigning is underway ahead of June’s European Parliament elections. This marks the beginning of a new chapter in the cycle of EU decision-making and offers us […]

By Oliver Bisazza Chief Executive Officer, MedTech Europe


Posted on 25.05.2018

IVDR/MDR transition periods: It’s time to talk about time

One year has now passed since the ‘new’ EU IVD and medical devices regulations entered into force. Since Day 1, the medical technology industry has been working at full capacity to achieve and maintain maximum possible readiness.  While I’d love to claim the same for all other essential elements of the new regulatory system, progress […]

By Oliver Bisazza Chief Executive Officer, MedTech Europe


Posted on 05.03.2018

Invest! Lead! Engage! Let’s Make Europe’s New Regulatory System Work

We are now over 15% of the transition period of the new European IVD Regulation (IVDR) and over 25% of the Medical Devices Regulation (MDR) transition. That said, transitioning to the new system comes with highly-ambitious timelines, and success will require great effort, by industry and authorities alike. Last week, at the Association of the […]

By Oliver Bisazza Chief Executive Officer, MedTech Europe


Posted on 27.11.2017

Notified Bodies: Into the Mouth of the Wolf?

At long last, the date has arrived.  Organisations who aspire to be Notified Bodies under the European IVD and medical devices regulations can submit their applications as of yesterday, 26 November 2017.  In order for the new regulatory system to function as intended, it is essential that these assessment bodies be up-and-running as early as […]

By Oliver Bisazza Chief Executive Officer, MedTech Europe